Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.26 USD | -1.91% |
|
+8.81% | -6.09% |
Jun. 07 | Recursion Pharmaceuticals Insider Sold Shares Worth $871,000, According to a Recent SEC Filing | MT |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.09% | 2.2B | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Earnings Flash (RXRX) RECURSION PHARMACEUTICALS Reports Q1 Revenue $13.8M, vs. Street Est of $12.7M